IL-12 reverses established antigen-specific tolerance of contact sensitivity by affecting costimulatory molecules B7-1 (CD80) and B7-2 (CD86)

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2080-2088

  Ushio, Hiroko ^a   Tsuji, Ryohei F ^b   Szczepanik, Marian ^d   Kawamoto, Keiko ^a   Matsuda, Hiroshi ^c   Askenase, Philip W ^e  

^a Osaka Prefecture University   (Japan)

^b Noda Institute for Scientific Research   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON C; B7 ANTIGEN; CD86 ANTIGEN; HAPTEN; INTERLEUKIN 12; MONOCLONAL ANTIBODY;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CELLS, CULTURED; DERMATITIS, CONTACT; EDEMA; EPITOPES; HAPTENS; IMMUNE TOLERANCE; INJECTIONS, INTRAVENOUS; INTERFERON TYPE II; INTERLEUKIN-12; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED CBA; T-LYMPHOCYTES;

EID: 0032031385     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Ptak, W., D. Rozycka, and M. Rewicka. 1979. Induction of suppressor cells and cells producing antigen-specific suppressor factors by hapten bound to self carriers. Immunobiology 156:400.
2. Ptak, W., M. Bereta, M. Ptak, G. M. Iverson, and D. R. Green. 1985. Suppression and contrasuppression in the induction of contact sensitivity by the administration of cell bound antigen-antibody complexes. J. Immunol. 135:2312.
3. Paliwal, V., A. M. Freedman, W. Ptak, and P. W. Askenase. 1994. Monoclonal, antigen-specific, T cell contrasuppressor factor expresses determinants of TCR α-chain (not necessarily TCR β-chain), having a molecular mass of about 40 kDa. J. Immunol. 152:2811.
4. Szczepanik, M., L. R. Anderson, H. Ushio, W. Ptak, M. J. Owen, A. C. Hayday, and P. W. Askenase. 1996. γδ T cells from tolerized αβ TCR deficient mice inhibit contact sensitivity effector T cells in vivo and their interferon-γ production in vitro. J. Exp. Med. 184:2129.
5. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon-γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
6. Manetti, R., P. Parronchi, M. G. Giudizi, M. Piccinni, E. Maggi, G. Trinchieri, and S. Romaanani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
7. Wolf, S. F., P. A. Temple, M. Kobayashi., D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fits, C. Ferenz, R. H. Hewick, K. Kelleher, S. H. Herrman, S. C. Clark, L. Azzoni, S. H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074.
8. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzomte, S. F. Wolf, and G. Trinchierri. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
9. Stern, A. S., F. J. Podlaski, J. D. Hulmes, Y.-C. E. Pan, P. M. Quinn, A. G. Woltizky, P. C. Familletti, D. L. Stremlo, T. Train, R. Chizzonite, and M. K. Gately. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87:6808.
10. Kobayashi, M., L. Fits, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. London, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170:827.
11. + T lymphocytes and NK cells. J. Immunol. 149:3495.
12. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
13. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260:496.
14. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
15. Murray, H. W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387.
16. Wynn, T. A., I. Eltoum, I. P. Oswald, A. W. Cheever, and A. Sher. 1994. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Shistasoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1551.
17. Finkelman, F. D., K. B. Madden, A. W. Cheever, I. M. Katona, S. C. Morris, M. K. Gately, B. R. Hubbard, W. C. Gause, and J. F. Urban, Jr. 1994. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179:1563.
18. Gavett, S. H., D. J. O'Hearn, X. Li, S.-K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1527.
19. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C. B-17 mice. J. Immunol. 152:1883.
20. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533.
21. Brunda, M. J., L. Luistro, R. R. Warrier, R. B. Wright, B. R. Hubbard, M. Murphy, S. F. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223.
22. Riemann, H., A. Schwarz, S. Grabbe, Y. Aragane, T. A. Luger, M. Wysocka, M. Kubin, G. Trinchieri, and T. Schwarz. 1996. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J. Immunol. 156:1799.
23. Müller, G., J. Saloga, T. Germann, G. Schuler, J. Knop, and A. H. Enk. 1995. IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J. Immunol. 155:4661.
24. Schmitt, D. A., L. Owen-Schaub, and S. E. Ullrich. 1995. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. J. Immunol. 154:5114.
25. Rivas, J. M., and S. E. Ullrich. 1992. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes: an essential role for keratinocyte-derived IL-10. J. Immunol. 149:3865.
26. Ullrich, S. E. 1994. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation: keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J. Immunol. 152:3410.
27. Niizeki, H., and J. W. Stereilein. 1997. Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin is mediated via interleukin-10. J. Invest. Dermatol. 109:25.
28. Alexander, H. E., J. Saloga, D. Becker, M. Mohamadzadeh, and J. Knop. 1994. Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 179:1397.
29. Dasch, J., D. R. Pace, W. Waegell, D. Inenaga, and L. Ellingsworth. 1989. Monoclonal antibodies recognizing transforming growth factor-β: bioactivity neutralization and transforming growth factor β2 affinity purification. J. Immunol. 142: 1536.
30. Rosenstein, R. W., J. H. Murry, R. E. Cone, W. Ptak, G. M. Iverson, and K. Gershon. 1981. Isolation and partial characterization of the antigen-specific T cell factor associated with the suppression of delayed-type hypersensitivity. Proc. Natl. Acad. Sci. USA 78:5821.
31. Simon, J. C., T. Mosmann, D. Edelbaum, E. Schopf, P. R. Bergstreser, and P. D. Cruz, Jr. 1994. In vivo evidence that ultraviolet B-induced suppression of allergic contact sensitivity is associated with functional inactivation of Th1 cells. Photodermatol. Photoimmunol. Photomed. 10:206.
32. Cher, D. J., and T. R. Mosmann. 1987. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J. Immunol. 138: 3688.
33. Fong, T. A. T., and T. R. Mosmann. 1989. The role of IFN-γ in delayed-type hypersensitivity mediated by Th1 clones. J. Immunol. 143:2887.
34. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
35. Wang, Z. E., S. Zheng, D. B. Corry, D. K. Dalton, R. A. Seder, S. L. Reiner, and R. M. Locksley. 1994. Interferon γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad. Sci. USA 91:12932.
36. Kubin, M., M. Kamoun, and G. Trinchieri. 1994. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180:211.
37. Ptak, W., W. R. Herzog, and P. W. Askenase. 1991. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-lype hypersensitivity effector T cells. J. Immunol. 146:469.
38. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
39. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 144:4121.
40. + T cells. J. Exp. Med. 183:1.
41. Wynn, T. A., D. Jankovic, S. Hieny, K. Zioncheck, P. Jardieu, A. W. Cheever, and A. Sher. 1995. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154:3999.
42. Maruo, S., K. Toyo-oka, M. Oh-hora, X.-G. Tai, H. Iwata, H. Takenaka, S. Yamada, S. Ono, T. Hamaoka, M. Kobayashi, M. Wysocka, G. Trinchieri, and H. Fujiwara. 1996. IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones. J. Immunol. 156:1748.
43. Murphy, E. E., G. Terres, S. E. Macatonia, C. Hsieh, I. Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy, and A. O'Garra. 1994. B7 and interleukin 12 cooperate for proliferation and interferon γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:223.
44. Gause, W. C., V. Mitro, C. Via, P. Linsely, J. F. Urban, and R. J. Greenwald. 1997. Do effector and memory T helper cells also need B7 ligand costimulatory signals? J. Immunol. 159:1055.
45. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M. N. Woodroofe, M. L. Cuzner, and D. A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985.
46. Guerder, S., J. Meyerhoff, and R. Flavell. 1994. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1:155.
47. Coughlin, C. M., M. Wysocka, H. L. Kurzawa, W. M. Lee, G. Trinchieri, and S. L. Eck. 1995. B7-1 and interleukin 12 synergistically induce effective antitumor immunity. Cancer Res. 55:4980.
48. Clerici, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721.